LUND, SWEDEN--(Marketwire - June 12, 2008) - Active Biotech's new issue with preferential rights for the company's shareholders has been completed. Nordstjernan AB and MGA Holding AB subscribed for their respective preferential part of the new issue. In addition hereto, Nordstjernan AB, that guaranteed the new issue, subscribed for a further 150,087 shares, corresponding to 3.8 per cent of the shares issued. Accordingly, the new issue was subscribed for in its entirety. Following the new issue, Nordstjernan AB and MGA Holding AB own 15.3 per cent and 30.0 per cent, respectively, of the shares and votes in Active Biotech.
